Summary
Many examples of successful drug development in pediatric populations
“Success” requires appropriate:
- evaluation of animal toxicology program, prior human experience
- consideration of disease/condition in adults and pediatrics and metabolic pathways of drug to assess relevance/extrapolation of adult efficacy data
- consideration of unique aspects of pediatric trials: alternative endpoints, issues in trial design and trial conduct